Novo Nordisk
NVO
#32
Rank
NZ$480.78 B
Marketcap
$97.85
Share price
-7.63%
Change (1 day)
-53.54%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): $4.62

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is $4.81. In 2022 the company made an earnings per share (EPS) of $3.66 an increase over its 2021 EPS that were of $3.35.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.6226.43%
2022$3.669.01%
2021$3.3515.08%
2020$2.9114.83%
2019$2.54-1.68%
2018$2.584.96%
2017$2.4631.08%
2016$1.88-10.33%
2015$2.0913.91%
2014$1.844.03%
2013$1.77-28.81%
2012$2.48108.9%
2011$1.1925.59%
2010$0.9535.01%
2009$0.70-9.17%
2008$0.7761.35%
2007$0.4828.96%
2006$0.3725.63%
2005$0.294.17%
2004$0.2813.55%
2003$0.2536.87%
2002$0.18-6.99%
2001$0.2021.56%
2000$0.1649.45%
1999$0.113.78%
1998$0.1012.15%
1997$0.0926424.74%
1996$0.07426

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.13-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.15 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.69 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.36 11.36%๐Ÿ‡ซ๐Ÿ‡ท France